Asthma history |
|
Age of asthma onset (y) |
3.52 ± 2.63 |
3.09 ± 2.40 |
3.66 ± 2.62 |
2.21 ± 1.89 |
2.27 ± 1.80 |
|
No. of subjects ever hospitalized for asthma (%) |
0 (0) |
0 (0) |
1 (0.46) |
225 (100) |
94 (97.9) |
|
ED visits for asthma (no./100 person-years) |
44.3 |
47.0 |
70.2 |
75.6 |
101 |
|
Atopic features |
|
History of AD (%) |
0 (0) |
202 (100) |
2 (0.1) |
0 (0) |
94 (97.9) |
|
History of hay fever (%) |
61 (20.3) |
132 (65.3) |
191 (87.6) |
119 (52.9) |
54 (56.3) |
|
History of positive skin test responses (%) |
230 (76.7) |
185 (91.6) |
209 (95.9) |
198 (88) |
92 (95.8) |
|
Total serum IgE levels (log10) |
2.37 ± 0.70 |
2.72 ± 0.72 |
2.79 ± 0.58 |
2.64 ± 0.61 |
2.81 ± 0.63 |
|
Spirometry |
|
Prebronchodilator FEV1 (% predicted) |
96.4 ± 12.7 |
97.7 ± 14.8 |
89.7 ± 13.9 |
91.4 ± 13.8 |
92.0 ± 16.1 |
|
Prebronchodilator FEV1/FVC (% predicted) |
81.8 ± 7.68 |
81.5 ± 7.59 |
77.6 ± 8.54 |
77.8 ± 8.24 |
78.6 ± 9.60 |
|
Prebronchodilator peak flow |
276.1 ± 67.3 |
274.3 ± 73.3 |
276.7 ± 69.1 |
276.4 ± 70.8 |
255.6 ± 73.3 |
|
Airway responsiveness |
|
Methacholine PC20 (natural log) |
0.71 ± 1.03 |
0.14 ± 1.11 |
−0.54 ± 1.00 |
0.038 ± 1.14 |
−0.23 ± 1.17 |
|
FEV1 bronchodilator response (L) |
0.077 ± 0.07 |
0.097 ± 0.08 |
0.12 ± 0.11 |
0.12 ± 0.11 |
0.16 ± 0.14 |
|
Anthropomorphic features |
|
BMI (kg/m2) |
18.1 ± 3.46 |
18.6 ± 3.83 |
18.5 ± 3.66 |
17.8 ± 3.19 |
17.6 ± 3.38 |
|
Waist/hip ratio |
0.882 ± 0.06 |
0.885 ± 0.07 |
0.881 ± 0.06 |
0.874 ± 0.05 |
0.877 ± 0.07 |
|
Peripheral blood counts |
|
Eosinophils (log10) |
2.35 ± 0.55 |
2.54 ± 0.53 |
2.57 ± 0.52 |
2.50 ± 0.49 |
2.71 ± 0.41 |
|
Lymphocytes (%) |
42.1 ± 11.5 |
40.9 ± 9.82 |
41.1 ± 10.9 |
41.7 ± 10.5 |
40.8 ± 9.78 |
|
Neutrophils (%) |
45.5 ± 12.2 |
44.5 ± 11.0 |
44.6 ± 11.5 |
44.7 ± 11.5 |
43.1 ± 11.0 |